Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A11QVV0
Tue, 01.10.2024
Heidelberg Pharma AG
Ad hoc announcement
Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma AG Announces Updated Guidance
Ladenburg, Germany, 1 October 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announces that it has adjusted it [ … ]
Tue, 18.06.2024
Heidelberg Pharma AG
Ad hoc announcement
Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma AG Announces Updated Guidance
Ladenburg, Germany, 18 June 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announces that it has adjusted its [ … ]
Mon, 04.03.2024
Heidelberg Pharma AG
Ad hoc announcement
Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
HealthCare Royalty to purchase royalties from worldwide sales of Telix Pharmaceuticals’ imaging diagnostic agent ZircaixTM (TLX250-CDx)
H [ … ]